Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2730-664X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit ; volume:3 ; number:1 ; day:7 ; month:2 ; year:2023 ; pages:1-14 ; date:12.2023
Communications medicine ; 3, Heft 1 (7.2.2023), 1-14, 12.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Tomlins, Scott A.
Khazanov, Nickolay A.
Bulen, Benjamin J.
Hovelson, Daniel H.
Shreve, Melissa J.
Lamb, Laura E.
Matrana, Marc R.
Burkard, Mark E.
Yang, Eddy Shih-Hsin
Edenfield, William Jeffery
Dees, E. Claire
Onitilo, Adedayo A.
Thompson, Michael
Buchschacher, Gary L.
Miller, Alan M.
Menter, Alexander
Parsons, Benjamin
Wassenaar, Timothy
Hwang, Leon C.
Suga, J. Marie
Siegel, Robert
Irvin, William
Nair, Suresh
Slim, Jennifer N.
Misleh, Jamal
Khatri, Jamil
Masters, Gregory
Thomas, Sachdev
Safa, Malek
Anderson, Daniel M.
Kwiatkowski, Kat
Mitchell, Khalis
Hu-Seliger, Tina
Drewery, Stephanie
Fischer, Andrew
Plouffe, Komal
Czuprenski, Eric
Hipp, Jennifer
Reeder, Travis
Vakil, Hana
Johnson, D. Bryan
Rhodes, Daniel R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-023-00243-7
- URN
-
urn:nbn:de:101:1-2023042921095974043218
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tomlins, Scott A.
- Khazanov, Nickolay A.
- Bulen, Benjamin J.
- Hovelson, Daniel H.
- Shreve, Melissa J.
- Lamb, Laura E.
- Matrana, Marc R.
- Burkard, Mark E.
- Yang, Eddy Shih-Hsin
- Edenfield, William Jeffery
- Dees, E. Claire
- Onitilo, Adedayo A.
- Thompson, Michael
- Buchschacher, Gary L.
- Miller, Alan M.
- Menter, Alexander
- Parsons, Benjamin
- Wassenaar, Timothy
- Hwang, Leon C.
- Suga, J. Marie
- Siegel, Robert
- Irvin, William
- Nair, Suresh
- Slim, Jennifer N.
- Misleh, Jamal
- Khatri, Jamil
- Masters, Gregory
- Thomas, Sachdev
- Safa, Malek
- Anderson, Daniel M.
- Kwiatkowski, Kat
- Mitchell, Khalis
- Hu-Seliger, Tina
- Drewery, Stephanie
- Fischer, Andrew
- Plouffe, Komal
- Czuprenski, Eric
- Hipp, Jennifer
- Reeder, Travis
- Vakil, Hana
- Johnson, D. Bryan
- Rhodes, Daniel R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors